Role of THSD1 and its Disease Causing Variants in Intracranial Aneurysm
THSD1 及其致病变异在颅内动脉瘤中的作用
基本信息
- 批准号:9543032
- 负责人:
- 金额:$ 33.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AKT Signaling PathwayAdultAffectAgeAge-MonthsAmericanAnimal ModelApoptosisAreaBiochemicalBiological AssayBiological ModelsBiologyBlood VesselsBrainCaliberCell physiologyCellsCerebral hemisphere hemorrhageCerebrovascular systemCessation of lifeClinicalDataDefectDiseaseDistalEarly DiagnosisEarly treatmentEndothelial CellsEtiologyExtracellular MatrixFamilyFocal Adhesion Kinase 1Focal AdhesionsFrequenciesFunctional disorderGenesGeneticGenetic ModelsGenetically Engineered MouseGoalsHemorrhageHumanHuman GeneticsHypertensionImpairmentIncidenceIntegrinsInternal carotid artery structureIntracranial AneurysmKineticsKnockout MiceLeadLesionLifeLiteratureMediatingMediator of activation proteinMolecularMonitorMorbidity - disease rateMusMutant Strains MicePECAM1 genePathway AnalysisPathway interactionsPericytesPermeabilityPopulationPrevalencePreventionPropertyProteinsReportingResearchRisk FactorsRoleRuptureRuptured AneurysmSignal PathwaySignal TransductionSmooth MuscleStrokeSubarachnoid HemorrhageSubarachnoid SpaceSurvival RateSurvivorsTalinTestingTherapeutic InterventionThickThrombospondinsTimeUnited StatesVariantVascular Endothelial CellWorkZebrafishbasebrain endothelial cellcerebral arterycerebrovascularcerebrovascular pathologydisabilitydisease phenotypeeffective therapyexome sequencinggenome-wide linkageimprovedin vivoknock-downloss of functionmortalitynovelprematurepreventprobandrare variantrhoshear stressstroke victimstooltranscriptome sequencing
项目摘要
An intracranial aneurysm (IA) is a weakened area in a cerebral artery wall that leads to
abnormal dilation and may rupture causing subarachnoid hemorrhage (SAH). Despite treatment
advances, the mortality of aneurysmal rupture is over 40%, and only one-half of survivors return
to independent life. In the United States alone, approximately 30,000 SAH cases occur
annually. Prior to rupture, IAs are usually asymptomatic and typically go unnoticed. When
identified and treated before rupture, survival rates dramatically improve. Therefore, early
detection, proper monitoring, and timely treatment of IAs are of paramount importance in
preventing disability and premature death. Our research team recently implicated rare variants
in thrombospondin-type 1 domain-containing protein 1 (THSD1) in both familial and sporadic IA
and SAH cases using human genetics and animal models. THSD1 is a poorly characterized
gene whose expression is largely restricted to endothelial cells. Here, we seek to elucidate the
key roles of THSD1 in brain vascular endothelial cells, using both a mouse knockout and human
brain endothelial cells. We will test the hypothesis that harmful THSD1 variants impair
endothelial cell function by perturbing focal adhesions leading to dysregulated signaling
mediated through focal adhesion kinase (FAK). This hypothesis is supported by our preliminary
data that includes an unbiased global pathway analysis of THSD1 human brain microvascular
endothelial knockdown cells. We anticipate that this research will elucidate in part the underlying
mechanism that leads to IA formation and rupture. Additionally, new discoveries will be made
with potential clinical impact for the early diagnosis and treatment of intracranial aneurysms,
thereby reducing morbidity and mortality. This work also has broader implications in vascular
biology as emerging evidence implicates Thsd1 in endothelial barrier function and in protection
of the vasculature in atherosclerotic and hemorrhagic lesions.
颅内动脉瘤(IA)是脑动脉壁中的弱区域,导致
异常扩张并可能破裂,导致蛛网膜下腔出血(SAH)。尽管有治疗
进步,动脉瘤破裂的死亡率超过40%,只有一半的幸存者返回
独立生活。仅在美国,大约发生了大约30,000个SAH案件
每年。在破裂之前,IAS通常是无症状的,通常不会引起注意。什么时候
在破裂前确定和治疗,生存率显着提高。因此,早
检测,适当的监测和及时对IAS的治疗至关重要
防止残疾和过早死亡。我们的研究小组最近牵涉到稀有变体
在血小板素型1中,含域的蛋白1(THSD1)在家族性和零星IA中均
和SAH病例使用人类遗传学和动物模型。 THSD1的特征很差
其表达在很大程度上仅限于内皮细胞的基因。在这里,我们试图阐明
THSD1在脑血管内皮细胞中的关键作用,同时使用小鼠敲除和人
脑内皮细胞。我们将测试有害THSD1变体损害的假设
内皮细胞功能通过扰动局灶性粘附,导致信号失调
通过局灶性粘附激酶(FAK)介导。这个假设得到了我们的初步支持
数据包括对THSD1人脑微血管的无偏全球途径分析
内皮敲低细胞。我们预计这项研究将部分阐明基础
导致IA形成和破裂的机制。此外,将有新发现
对颅内动脉瘤的早期诊断和治疗具有潜在的临床影响,
从而降低发病率和死亡率。这项工作在血管中也具有更广泛的影响
生物学作为新兴证据牵涉到内皮屏障功能和保护中的THSD1
动脉粥样硬化和出血性病变中的脉管系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dong H Kim其他文献
Dong H Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dong H Kim', 18)}}的其他基金
Role of THSD1 and its Disease Causing Variants in Intracranial Aneurysm
THSD1 及其致病变异在颅内动脉瘤中的作用
- 批准号:
9886293 - 财政年份:2018
- 资助金额:
$ 33.69万 - 项目类别:
The Role of THSD1 in Endothelial Cell Adhesion and Survival
THSD1 在内皮细胞粘附和存活中的作用
- 批准号:
8824389 - 财政年份:2014
- 资助金额:
$ 33.69万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Role of PD1 blockade and IL-10 during infection in aging
PD1 阻断和 IL-10 在衰老感染过程中的作用
- 批准号:
10509657 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
The cellular molecular regulation of differing mechanisms of insulin resistance.
胰岛素抵抗不同机制的细胞分子调节。
- 批准号:
10531044 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
The cellular molecular regulation of differing mechanisms of insulin resistance.
胰岛素抵抗不同机制的细胞分子调节。
- 批准号:
10661826 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
Role of PD1 blockade and IL-10 during infection in aging
PD1 阻断和 IL-10 在衰老感染过程中的作用
- 批准号:
10704181 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别:
AS160 as a nodal regulator of the cardiac response to metabolic stress
AS160 作为心脏对代谢应激反应的节点调节剂
- 批准号:
10518319 - 财政年份:2022
- 资助金额:
$ 33.69万 - 项目类别: